The economic impact of compassionate use of medicines
Abstract Background Compassionate use programs (CUP) for medicines respond to the ethical imperative of providing access to medicines before marketing approval to patients not recruited in trials. The economic impact of clinical trials has previously been investigated. No evidence on the net economi...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f41042770fd5499b9a7e061ca48ac62e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|